Federica Alamia

9PUBLICATIONS
11CO-AUTHORS
Molecular targetsMedical devicesHaematological tumoursCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
Imidazole-Functionalized Thieno[3,2-c]Quinoline Hybrids in Aggressive Medullary Thyroid Cancer Cell Models: Biological Evaluation and in Silico Insights.

|Jun 26, 2026
B.R.E.A.S.T. Breast canceR Enhanced AI-Supported Therapy: A New Interpretable Proteomics-Driven Machine Learning Framework for Therapy Response Prediction in Breast Cancer.

|Oct 29, 2025
A Hybrid In Silico Approach for Identifying Dual VEGFR/RAS Inhibitors as Potential Anticancer and Anti-Angiogenic Agents.

Alessia Bono, Gabriele La Monica, Federica Alamia

|Feb 06, 2025
Design, Synthesis, and In Silico Insights of new 4-Piperazinylquinolines as Antiproliferative Agents against NCI Renal Cancer Cell Lines.

Gabriele La Monica, Alessia Bono, Federica Alamia

|Jan 11, 2025
Novel Antibacterial 4-Piperazinylquinoline Hybrid Derivatives Against Staphylococcus aureus: Design, Synthesis, and In Vitro and In Silico Insights.

Gabriele La Monica, Annamaria Gallo, Alessia Bono

|Jan 08, 2025
In Silico Design of Dual Estrogen Receptor and Hsp90 Inhibitors for ER-Positive Breast Cancer Through a Mixed Ligand/Structure-Based Approach.

Gabriele La Monica, Federica Alamia, Alessia Bono

Pageof 2

Frequent Collaborators

9 joint publications

Alessia Bono

9 joint publications

Antonino Lauria

9 joint publications

Gabriele La Monica

9 joint publications

Annamaria Martorana